Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Kjell Ohlsson

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Anatomy

Procedures

Gel Chromatography

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
20
Borgström, Anders
17
Lasson, Ake
8
Linder, Carina
6
Westin, Ulla
5
Nyström, M
4
Lindgärde, Folke
4
Sveger, Tomas
3
Möller, Halvor
3
Bruze, Magnus
3
Ohlsson, Sophie
3
Ljungcrantz, I
3
Björkner, Bert
3
Falke, P
3
Elneihoum, AM
2
Abrahamson, Magnus

Sign-in to see all Coauthors

Publications

TOP 3
Piitulainen Eeva; Carlson Joyce; Ohlsson Kjell; Sveger Tomas
Alpha1-antitrypsin deficiency in 26-year-old subjects: lung, liver, and protease/protease inhibitor studies.
Ohlsson S; Falk R; Yang J J; Ohlsson K; Segelmark M; Wieslander J
Increased expression of the secretory leukocyte proteinase inhibitor in Wegener's granulomatosis.
Sveger T; Ohlsson K; Mörse H; Polberger S; Laurin S
Plasma neutrophil lipocalin, elastase-alpha1-antitrypsin complex and neutrophil protease 4 in preterm infants with respiratory distress syndrome.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Kjell Ohlsson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2005: Piitulainen Eeva; Carlson Joyce; Ohlsson Kjell; Sveger Tomas
Alpha1-antitrypsin deficiency in 26-year-old subjects: lung, liver, and protease/protease inhibitor studies.
Chest 2005;128(4):2076-81.
2003: Ohlsson S; Falk R; Yang J J; Ohlsson K; Segelmark M; Wieslander J
Increased expression of the secretory leukocyte proteinase inhibitor in Wegener's granulomatosis.
Clinical and experimental immunology 2003;131(1):190-6.
2003: Sveger T; Ohlsson K; Mörse H; Polberger S; Laurin S
Plasma neutrophil lipocalin, elastase-alpha1-antitrypsin complex and neutrophil protease 4 in preterm infants with respiratory distress syndrome.
Scandinavian journal of clinical and laboratory investigation 2003;63(2):89-92.
2002: Ersson Anders; Walles Maria; Ohlsson Kjell; Ekholm Anders
Chronic hyperbaric exposure activates proinflammatory mediators in humans.
Journal of applied physiology (Bethesda, Md. : 1985) 2002;92(6):2375-80.
2002: Westin U; Nyström M; Ljungcrantz I; Eriksson B; Ohlsson K
The presence of elafin, SLPI, IL1-RA and STNFalpha RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation.
Mediators of inflammation 2002;11(1):7-12.
2002: Gottsäter A; Forsblad J; Mätzsch T; Persson K; Ljungcrantz I; Ohlsson K; Lindgärde F
Interleukin-1 receptor antagonist is detectable in human carotid artery plaques and is related to triglyceride levels and Chlamydia pneumoniae IgA antibodies.
Journal of internal medicine 2002;251(1):61-8.
2002: Sveger T; Ohlsson K; Polberger S; Noack G; Mörse H; Laurin S
Tracheobronchial aspirate fluid neutrophil lipocalin, elastase- and neutrophil protease-4-alpha1-antitrypsin complexes, protease inhibitors and free proteolytic activity in respiratory distress syndrome.
Acta paediatrica (Oslo, Norway : 1992) 2002;91(9):934-7.
2002: Svensson Ake; Möller Halvor; Björkner Bert; Bruze Magnus; Leden Ido; Theander Jan; Ohlsson Kjell; Linder Carina
Rheumatoid arthritis, gold therapy, contact allergy and blood cytokines.
BMC dermatology 2002;2():2.
2001: Ohlsson S; Ljungkrantz I; Ohlsson K; Segelmark M; Wieslander J
Novel distribution of the secretory leucocyte proteinase inhibitor in kidney.
Mediators of inflammation 2001;10(6):347-50.
2001: Nyström M; Westin U P; Linder C; Ohlsson K
Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa.
Mediators of inflammation 2001;10(5):269-72.
2000: Falke P; Elneihoum A M; Ohlsson K
Leukocyte activation: relation to cardiovascular mortality after cerebrovascular ischemia.
Cerebrovascular diseases (Basel, Switzerland) 2000;10(2):97-101.
1999: Westin U; Lundberg E; Wihl J A; Ohlsson K
The effect of immediate-hypersensitivity reactions on the level of SLPI, granulocyte elastase, alpha1-antitrypsin, and albumin in nasal secretions, by the method of unilateral antigen challenge.
Allergy 1999;54(8):857-64.
1999: Westin U; Polling A; Ljungkrantz I; Ohlsson K
Identification of SLPI (secretory leukocyte protease inhibitor) in human mast cells using immunohistochemistry and in situ hybridisation.
Biological chemistry 1999;380(4):489-93.
1999: Möller H; Ohlsson K; Linder C; Björkner B; Bruze M
The flare-up reactions after systemic provocation in contact allergy to nickel and gold.
Contact dermatitis 1999;40(4):200-4.
1999: Nyström M; Bergenfeldt M; Ljungcrantz I; Lindeheim A; Ohlsson K
Production of secretory leucocyte protease inhibitor (SLPI) in human pancreatic beta-cells.
Mediators of inflammation 1999;8(3):147-51.
1998: Sveger T; Ohlsson K; Piitulainen E
Adolescents with alpha1-antitrypsin deficiency have high alpha2-macroglobulin and low neutrophil lipocalin and elastase levels in plasma.
Pediatric research 1998;44(6):939-41.
1998: Anwaar I; Gottsäter A; Ohlsson K; Mattiasson I; Lindgärde F
Increasing levels of leukocyte-derived inflammatory mediators in plasma and cAMP in platelets during follow-up after acute cerebral ischemia.
Cerebrovascular diseases (Basel, Switzerland) 1998;8(6):310-7.
1998: Möller H; Ohlsson K; Linder C; Björkner B; Bruze M
Cytokines and acute phase reactants during flare-up of contact allergy to gold.
American journal of contact dermatitis : official journal of the American Contact Dermatitis Society 1998;9(1):15-22.
1998: Westin U; Lundberg E; Ohlsson K
IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release.
Mediators of inflammation 1998;7(3):217-20.
1997: Ohlsson S; Tufvesson B; Polling A; Ohlsson K
Distribution of the secretory leucocyte proteinase inhibitor in human articular cartilage.
Biological chemistry 1997;378(9):1055-8.
1997: Elneihoum A M; Falke P; Hedblad B; Lindgärde F; Ohlsson K
Leukocyte activation in atherosclerosis: correlation with risk factors.
Atherosclerosis 1997;131(1):79-84.
1997: Nyström M; Bergenfeldt M; Ohlsson K
The elimination of secretory leukocyte protease inhibitor (SLPI) from the gastrointestinal tract in man.
Scandinavian journal of clinical and laboratory investigation 1997;57(2):119-25.
1996: Elneihoum A M; Falke P; Axelsson L; Lundberg E; Lindgärde F; Ohlsson K
Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases.
Stroke; a journal of cerebral circulation 1996;27(10):1734-8.
1996: Ohlsson K; Linder C; Lundberg E; Axelsson L
Release of cytokines and proteases from human peripheral blood mononuclear and polymorphonuclear cells following phagocytosis and LPS stimulation.
Scandinavian journal of clinical and laboratory investigation 1996;56(5):461-70.
1996: Jönsson P; Linder C; Genell S; Ohlsson K
Extrapancreatic origin of the pancreatic secretory trypsin inhibitor as an acute-phase reactant.
Pancreas 1996;12(3):303-7.
1996: Bergenfeldt M; Nyström M; Bohe M; Lindström C; Polling A; Ohlsson K
Localization of immunoreactive secretory leukocyte protease inhibitor (SLPI) in intestinal mucosa.
Journal of gastroenterology 1996;31(1):18-23.
1995: Axelsson L; Bergenfeldt M; Ohlsson K
Studies of the release and turnover of a human neutrophil lipocalin.
Scandinavian journal of clinical and laboratory investigation 1995;55(7):577-88.
1995: Jönsson P; Borgström A; Steen S; Ohlsson K
Trypsinogen is not activated during cardiac surgery with extracorporeal circulation.
Scandinavian journal of clinical and laboratory investigation 1995;55(5):441-5.
1995: Jönsson P; Ohlsson K
Intrapancreatic turnover of recombinant human pancreatic secretory trypsin inhibitor in experimental porcine pancreatitis.
Scandinavian journal of clinical and laboratory investigation 1995;55(3):223-7.
1995: Bohe H; Bohe M; Lindström C; Ohlsson K
Pancreatic secretory trypsin inhibitor in human Brunner's glands.
Journal of gastroenterology 1995;30(1):90-5.
1995: Ohlsson K; Bjartell A; Lilja H
Secretory leucocyte protease inhibitor in the male genital tract: PSA-induced proteolytic processing in human semen and tissue localization.
Journal of andrology 1995;16(1):64-74.
1994: Jönsson P; Ljungcrantz I; Ohlsson K
Prevention of trypsin-induced shock in rats by the pancreatic secretory trypsin inhibitor.
Scandinavian journal of clinical and laboratory investigation 1994;54(8):595-9.
1994: Bläckberg M; Ohlsson K
Interactions in vitro and in vivo between porcine tissue kallikrein and porcine plasma proteinase inhibitors.
Scandinavian journal of clinical and laboratory investigation 1994;54(8):643-51.
1994: Bergenfeldt M; Berling R; Ohlsson K
Levels of leukocyte proteases in plasma and peritoneal exudate in severe, acute pancreatitis.
Scandinavian journal of gastroenterology 1994;29(4):371-5.
1994: Westin U; Fryksmark U; Polling A; Ohlsson K
Localisation of secretory leucocyte proteinase inhibitor mRNA in nasal mucosa.
Acta oto-laryngologica 1994;114(2):199-202.
1994: Jönsson P; Källén R; Borgström A; Ohlsson K
Exocrine pancreatic proteins in serum during pancreatic allograft rejection.
Pancreas 1994;9(2):244-8.
1994: Bläckberg M; Ohlsson K
Studies on the release of tissue kallikrein in experimental pancreatitis in the pig.
European surgical research. Europäische chirurgische Forschung. Recherches chirurgicales européennes 1994;26(2):116-24.
1993: Björk P; Luts A; Sundler F; Ohlsson K
Turnover and distribution of cathepsin G in the rat.
Scandinavian journal of clinical and laboratory investigation 1993;53(6):539-46.
1993: Bergenfeldt M; Ohlsson K
Protease-antiprotease levels and whole-blood chemiluminescence in acute peritonitis.
Gastroenterologia Japonica 1993;28(5):687-98.
1992: Bohe H; Bohe M; Jönsson P; Lindström C; Ohlsson K
Quantification of pancreatic secretory trypsin inhibitor in colonic carcinoma and normal adjacent colonic mucosa.
Journal of clinical pathology 1992;45(12):1066-9.
1992: Bergenfeldt M; Axelsson L; Ohlsson K
Release of neutrophil proteinase 4(3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors.
Scandinavian journal of clinical and laboratory investigation 1992;52(8):823-9.
1992: Ohlsson K; Sveger T; Svenningsen N
Protease inhibitors in bronchoalveolar lavage fluid from neonates with special reference to secretory leukocyte protease inhibitor.
Acta paediatrica (Oslo, Norway : 1992) 1992;81(10):757-9.
1992: Håkansson H O; Ohlsson K
Influence of plasma proteinase inhibitors and the secretory leucocyte proteinase inhibitor on pancreatic elastase-induced degradation of some plasma proteins.
Gastroenterologia Japonica 1992;27(5):652-6.
1992: Jönsson P; Borgström A; Ohlsson K
Measurements of exocrine proteins in the pig pancreas using microdialysis.
Gastroenterologia Japonica 1992;27(4):529-35.
1992: Bergenfeldt M; Linder C; Ohlsson K
Stimulation of human polymorphonuclear leukocytes by recombinant human interleukin-1 beta.
Biological chemistry Hoppe-Seyler 1992;373(5):255-60.
1992: Sveger T; Ohlsson K; Svenningsen N
Neonatal plasma concentrations of secretory leucocyte protease inhibitor.
Acta paediatrica (Oslo, Norway : 1992) 1992;81(3):270-1.
1991: Jönsson-Berling B M; Ohlsson K
Distribution and elimination of intravenously injected urinary trypsin inhibitor.
Scandinavian journal of clinical and laboratory investigation 1991;51(6):549-57.
1991: Håkansson H O; Borgström A; Ohlsson K
Porcine pancreatic cationic pro-elastase. Studies on the activation, turnover and interaction with plasma proteinase inhibitors.
Biological chemistry Hoppe-Seyler 1991;372(7):465-72.
1991: Björk P; Axelsson L; Ohlsson K
Release of dog polymorphonuclear leukocyte cathepsin G, normally and in endotoxin and pancreatitic shock. Isolation and partial characterization of dog polymorphonuclear leukocyte cathepsin G.
Biological chemistry Hoppe-Seyler 1991;372(6):419-26.
1991: Lasson A; Berling R; Göransson J; Ohlsson K
Alpha-2-macroglobulin decreases parallel to albumin and haemoglobin after elective surgery.
Scandinavian journal of clinical and laboratory investigation 1991;51(3):225-33.
1991: Bohe H; Bohe M; Lindström C; Ohlsson K
Immunoreactive pancreatic secretory trypsin inhibitor in normal, inflammatory and neoplastic gallbladders.
Gastroenterologia Japonica 1991;26(1):95-8.
1991: Abrahamson M; Mason R W; Hansson H; Buttle D J; Grubb A; Ohlsson K
Human cystatin C. role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase.
The Biochemical journal 1991;273 ( Pt 3)():621-6.
1991: Lundberg E; Bergenfeldt M; Ohlsson K
Release of immunoreactive human neutrophil proteinase 4, normally and in peritonitis.
Scandinavian journal of clinical and laboratory investigation 1991;51(1):23-9.
1991: Håkansson H; Borgström A; Ohlsson K
Pancreatic cationic elastase in porcine experimental pancreatitis.
European surgical research. Europäische chirurgische Forschung. Recherches chirurgicales européennes 1991;23(2):73-84.
1991: Abrahamson M; Buttle D J; Mason R W; Hansson H; Grubb A; Lilja H; Ohlsson K
Regulation of cystatin C activity by serine proteinases.
Biomedica biochimica acta 1991;50(4-6):587-93.
1991: Delshammar M; Lasson A; Ohlsson K
Uptake of immunoreactive leukocyte elastase-inhibitor complexes in macrophage-like cells in abscesses.
European surgical research. Europäische chirurgische Forschung. Recherches chirurgicales européennes 1991;23(3-4):256-60.
1990: Ohlsson K; Björk P; Bergenfeldt M; Hageman R; Thompson R C
Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.
Nature 1990;348(6301):550-2.
1990: Bergenfeldt M; Björk P; Ohlsson K
The elimination of secretory leukocyte protease inhibitor (SLPI) after intravenous injection in dog and man.
Scandinavian journal of clinical and laboratory investigation 1990;50(7):729-37.
1990: Bohe H; Bohe M; Lindström C; Ohlsson K
Immunohistochemical demonstration of pancreatic secretory trypsin inhibitor in normal and neoplastic colonic mucosa.
Journal of clinical pathology 1990;43(11):901-4.
1990: Björk P; Ohlsson K
Purification and N-terminal amino-acid sequence analysis of rat polymorphonuclear leukocyte cathepsin G.
Biological chemistry Hoppe-Seyler 1990;371(7):595-601.
1990: Ohlsson K; Linder C; Rosengren M
Monoclonal antibodies specific for neutrophil proteinase 4. Production and use for isolation of the enzyme.
Biological chemistry Hoppe-Seyler 1990;371(7):549-55.
1990: Axelsson L; Bergenfeldt M; Björk P; Olsson R; Ohlsson K
Release of immunoreactive canine leukocyte elastase normally and in endotoxin and pancreatitic shock.
Scandinavian journal of clinical and laboratory investigation 1990;50(1):35-42.
1989: Borgström A; Lasson A; Ohlsson K
Patterns of immunoreactive trypsin in serum from patients with acute abdominal disorders.
Scandinavian journal of clinical and laboratory investigation 1989;49(8):757-62.
1989: Jönsson-Berling B M; Ohlsson K; Rosengren M
Radioimmunological quantitation of the urinary trypsin inhibitor in normal blood and urine.
Biological chemistry Hoppe-Seyler 1989;370(11):1157-61.
1989: Lasson A; Göransson J; Ohlsson K
Pancreatic pseudocyst fluid--a mixture of plasma proteins and pancreatic juice possessing a high proteolytic activity.
Scandinavian journal of clinical and laboratory investigation 1989;49(5):403-12.
1989: Delshammar M; Lasson A; Ohlsson K
Proteases and protease inhibitor balance in peritonitis with different causes.
Surgery 1989;106(3):555-62.
1989: Ohlsson K; Olsson R; Björk P; Balldin G; Borgström A; Lasson A; Kohno T; Thompson R C
Local administration of human pancreatic secretory trypsin inhibitor prevents the development of experimental acute pancreatitis in rats and dogs.
Scandinavian journal of gastroenterology 1989;24(6):693-704.
1989: Håkansson B; Linder C; Ohlsson K; Tegner H; Toremalm N G
The inhibition of granulocyte phagocytosis by various components of nasal drops.
Pharmacology & toxicology 1989;65(2):89-91.
1989: Fryksmark U; Jannert M; Ohlsson K; Tegner H; Wihl J A
Secretory leukocyte protease inhibitor in normal, allergic and virus induced nasal secretions.
Rhinology 1989;27(2):97-103.
1989: Delshammar M; Lasson A; Nilsson I M; Ohlsson K; Wallmark A; Vernersson E
Abnormal proteolysis (DIC)--successful treatment with antithrombin III concentrate and a concentrate containing F XIII and native von Willebrand factor.
Journal of internal medicine 1989;225(1):21-7.
1989: Balldin G; Genell S; Ohlsson K
Pancreatic abscess: formation, diagnostic procedures and treatment.
Digestive diseases (Basel, Switzerland) 1989;7(2):104-12.
1989: Hjelmqvist B; Wattsgård C; Borgström A; Lasson A; Nyman U; Aspelin P; Ohlsson K
Early diagnosis and classification in acute pancreatitis. A comparison of clinical outcome with findings at computed tomography and Ranson's prognostic signs.
Digestion 1989;44(4):177-83.
1989: Hjelmqvist B; Wattsgård C; Borgström A; Lasson A; Nyman U; Ohlsson K
Pathobiochemistry and early CT findings in acute pancreatitis.
Digestion 1989;44(4):184-90.
1989: Lasson A; Berling R; Ohlsson K
CRP predicts complications in pancreatitis and peritonitis.
Progress in clinical and biological research 1989;308():725-9.
1988: Hjelmqvist B; Borgström A; Ohlsson K
Interactions in vitro and in vivo between anionic and cationic porcine trypsin and porcine plasma proteinase inhibitors.
Biological chemistry Hoppe-Seyler 1988;369(12):1331-6.
1988: Axelsson L; Linder C; Ohlsson K; Rosengren M
The effect of the secretory leukocyte protease inhibitor on leukocyte proteases released during phagocytosis.
Biological chemistry Hoppe-Seyler 1988;369 Suppl():89-93.
1988: Håkansson H O; Ohlsson K
Interactions in vitro and in vivo between human and porcine cationic pancreatic elastase and plasma protease inhibitors.
Biological chemistry Hoppe-Seyler 1988;369(4):309-15.
1988: Björk P; Axelsson L; Bergenfeldt M; Ohlsson K
Influence of plasma protease inhibitors and the secretory leucocyte protease inhibitor on leucocyte elastase-induced consumption of selected plasma proteins in vitro in man.
Scandinavian journal of clinical and laboratory investigation 1988;48(2):205-11.
1988: Ohlsson K; Bergenfeldt M; Björk P
Functional studies of human secretory leukocyte protease inhibitor.
Advances in experimental medicine and biology 1988;240():123-31.
1988: Lasson A; Delshammar M; Ohlsson K
Local and general defence mechanisms in bacterial and chemical peritonitis.
Advances in experimental medicine and biology 1988;240():433-40.
1988: Bohe M; Lindström C; Ohlsson K
Immunoreactive pancreatic secretory trypsin inhibitor in gastrointestinal mucosa.
Advances in experimental medicine and biology 1988;240():101-5.
1988: Lasson A; Ohlsson K
Systemic involvement in pancreatic damage: coagulation and fibrinolysis.
International journal of pancreatology : official journal of the International Association of Pancreatology 1988;3 Suppl 1():S79-86.
1988: Ohlsson K; Balldin G; Bohe M; Borgström A; Genell S; Lasson A
Pancreatic proteases and antiproteases in pancreatic disease; biochemical, pathophysiological and clinical aspects.
International journal of pancreatology : official journal of the International Association of Pancreatology 1988;3 Suppl 1():S67-78.
1987: Bohe M; Lindström C G; Ohlsson K
Varying occurrence of gastroduodenal immunoreactive pancreatic secretory trypsin inhibitor.
Journal of clinical pathology 1987;40(11):1345-8.
1986: Bohe M; Borgström A; Lindström C; Ohlsson K
Pancreatic endoproteases and pancreatic secretory trypsin inhibitor immunoreactivity in human Paneth cells.
Journal of clinical pathology 1986;39(7):786-93.
1986: Bohe M; Genell S; Ohlsson K
Protease inhibitors in plasma and faecal extracts from patients with active inflammatory bowel disease.
Scandinavian journal of gastroenterology 1986;21(5):598-604.
1986: Lasson A; Balldin G; Ohlsson K
Leukocyte elastase alpha 1-proteinase inhibitor complexes may diagnose pancreatic abscesses early.
Scandinavian journal of gastroenterology 1986;21(2):221-4.
1986: Bohe M; Borgström A; Genell S; Ohlsson K
Metabolism of 131I-labelled human pancreatic cationic trypsin after intraduodenal administration.
Digestion 1986;34(2):127-35.
1986: Bohe M; Borgström A; Genell S; Ohlsson K
Characterization of radioactivity in plasma after intraduodenal administration of 131I-labelled human cationic trypsin.
Scandinavian journal of gastroenterology. Supplement 1986;126():21-4.
1986: Bohe M; Lindström C; Ohlsson K
Immunohistochemical demonstration of pancreatic secretory proteins in human paneth cells.
Scandinavian journal of gastroenterology. Supplement 1986;126():65-8.
1985: Fryksmark U; Jannert M; Ohlsson K; Tegner H
Antileukoprotease in patients with maxillary sinusitis.
Rhinology 1985;23(3):247-51.
1985: Tegner H; Fryksmark U; Ohlsson K
The mucosal defence capacity against proteolytic leukocyte enzymes.
European journal of respiratory diseases. Supplement 1985;139():62-5.
1984: Balldin G; Lasson A; Ohlsson K
Aprotinin turn-over studies in dog and in man with severe acute pancreatitis.
Hoppe-Seyler's Zeitschrift für physiologische Chemie 1984;365(12):1417-23.
1984: Lasson A; Balldin G; Ohlsson K
Gabexate mesilate (FOY) and aprotinin. A comparative study of the effects on trypsin-induced activation of the kinin and complement systems in vivo and in vitro.
Hoppe-Seyler's Zeitschrift für physiologische Chemie 1984;365(12):1409-15.
1984: Ohlsson M; Fryksmark U; Polling A; Tegner H; Ohlsson K
Localization of antileukoprotease in the parotid and the submandibular salivary glands.
Acta oto-laryngologica 1984;98(1-2):147-51.
1984: Balldin G; Borgström A; Marks W H; Ohlsson K
On the role of the pancreatic secretory trypsin inhibitor as an inactivator of trypsin-alpha 2-macroglobulin complexes in acute pancreatitis.
Hoppe-Seyler's Zeitschrift für physiologische Chemie 1984;365(7):751-6.
1984: Fryksmark U; Prellner T; Tegner H; Ohlsson K
Studies on the role of antileukoprotease in respiratory tract diseases.
European journal of respiratory diseases 1984;65(3):201-9.
1984: Bohe M; Borgström A; Genell S; Ohlsson K
Fate of intravenously injected trypsin in dog with special reference to the existence of an enteropancreatic circulation.
Digestion 1984;29(3):158-63.
1984: Bohe M; Borgström A; Lindström C; Ohlsson K
Trypsin-like immunoreactivity in human Paneth cells.
Digestion 1984;30(4):271-5.
1984: Lasson A; Balldin G; Genell S; Ohlsson K
Peritoneal lavage in severe acute pancreatitis.
Acta chirurgica Scandinavica 1984;150(6):479-84.
1984: Ohlsson K; Fryksmark U; Ohlsson M; Tegner H
Interaction of granulocyte proteases with inhibitors in pulmonary diseases.
Advances in experimental medicine and biology 1984;167():299-312.
1983: Ohlsson M; Rosengren M; Tegner H; Ohlsson K
Quantification of granulocyte elastase inhibitors in human mixed saliva and in pure parotid secretion.
Hoppe-Seyler's Zeitschrift für physiologische Chemie 1983;364(9):1323-8.
1983: Fryksmark U; Ohlsson K; Rosengren M; Tegner H
Studies on the interaction between leukocyte elastase, antileukoproteinase and the plasma proteinase inhibitors alpha 1-proteinase inhibitor and alpha 2-macroglobulin.
Hoppe-Seyler's Zeitschrift für physiologische Chemie 1983;364(7):793-800.
1983: Fryksmark U; Ohlsson K; Tegner H
The mucosal defence capacity against proteolytic leukocyte enzymes.
Rhinology 1983;21(1):39-43.
1983: Bohe M; Borgström A; Genell S; Ohlsson K
Determination of immunoreactive trypsin, pancreatic elastase and chymotrypsin in extracts of human feces and ileostomy drainage.
Digestion 1983;27(1):8-15.
1983: Balldin G; Borgström A; Genell S; Ohlsson K
The effect of peritoneal lavage and aprotinin in the treatment of severe acute pancreatitis.
Research in experimental medicine. Zeitschrift für die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie 1983;183(3):203-13.
1982: Fryksmark U; Ohlsson K; Polling A; Tegner H
Distribution of antileukoprotease in upper respiratory mucosa.
The Annals of otology, rhinology, and laryngology 1982;91(3 Pt 1):268-71.
1981: Fryksmark U; Ohlsson K; Rosengren M; Tegner H
A radioimmunoassay for measurement and characterization of human antileukoprotease in serum.
Hoppe-Seyler's Zeitschrift für physiologische Chemie 1981;362(9):1273-7.
1981: Balldin G; Eddeland A; Ohlsson K
Studies on the role of the plasma protease inhibitors on in vitro C3 activation and in acute pancreatitis.
Scandinavian journal of gastroenterology 1981;16(5):603-9.
1980: Ohlsson K; Fryksmark U; Tegner H
The effect of cigarette smoke condensate on alpha 1-antitrypsin, antileukoprotease and granulocyte elastase.
European journal of clinical investigation 1980;10(5):373-9.
1980: Balldin G; Borgström A; Eddeland A; Genell S; Hagberg L; Ohlsson K
Elevated serum levels of pancreatic secretory proteins in cigarette smokers after secretin stimulation.
The Journal of clinical investigation 1980;66(1):159-62.

Sign-in to see more